BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30393811)

  • 1. CXCL9 chemokine in ulcerative colitis.
    Elia G; Guglielmi G
    Clin Ter; 2018; 169(5):e235-e241. PubMed ID: 30393811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Th1 chemokines in ulcerative colitis.
    Ragusa F
    Clin Ter; 2015; 166(2):e126-31. PubMed ID: 25945446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIG in Crohn's disease.
    Caruso C
    Clin Ter; 2019; 170(3):e206-e210. PubMed ID: 31173051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha chemokines in Crohn's disease.
    Devito A
    Clin Ter; 2015; 166(2):e114-7. PubMed ID: 25945443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The proinflammatory CXC-chemokines GRO-alpha/CXCL1 and MIG/CXCL9 are concomitantly expressed in ulcerative colitis and decrease during treatment with topical corticosteroids.
    Egesten A; Eliasson M; Olin AI; Erjefält JS; Bjartell A; Sangfelt P; Carlson M
    Int J Colorectal Dis; 2007 Dec; 22(12):1421-7. PubMed ID: 17703315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermatomyositis and MIG.
    Ragusa F
    Clin Ter; 2019; 170(2):e142-e147. PubMed ID: 30993311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcoidosis and the Th1 chemokine MIG.
    Ragusa F
    Clin Ter; 2018; 169(6):e308-e313. PubMed ID: 30554254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of autoimmune hepatitis is mediated by IL-18-producing dendritic cells and hepatic CXCL9 expression in mice.
    Ikeda A; Aoki N; Kido M; Iwamoto S; Nishiura H; Maruoka R; Chiba T; Watanabe N
    Hepatology; 2014 Jul; 60(1):224-36. PubMed ID: 24700550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MIG Th1 chemokine in Vitiligo.
    Elia G
    Clin Ter; 2018; 169(6):e303-e307. PubMed ID: 30554253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interaction.
    Manousou P; Kolios G; Drygiannakis I; Pyrovolaki K; Bourikas L; Papadaki HA; Kouroumalis E
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1823-33. PubMed ID: 18761554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheumatoid arthritis and the Th1 chemokine MIG.
    Paparo SR
    Clin Ter; 2019; 170(6):e472-e477. PubMed ID: 31696912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Th1 chemokine MIG in Graves' ophthalmopathy.
    Gonnella D
    Clin Ter; 2019; 170(5):e368-e372. PubMed ID: 31612195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcoidosis and the alpha chemokine MIG.
    Giusti C
    Clin Ter; 2020; 171(2):e161-e166. PubMed ID: 32141489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MIG in Cutaneous Systemic Lupus Erythematosus.
    Ruffilli I
    Clin Ter; 2019; 170(1):e71-e76. PubMed ID: 30789201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 1 diabetes and MIG.
    Gonnella D
    Clin Ter; 2019; 170(6):e465-e471. PubMed ID: 31696911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The MIG Chemokine in Inflammatory Myopathies.
    Paparo SR
    Clin Ter; 2019; 170(1):e55-e60. PubMed ID: 30789198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans.
    Wasmuth HE; Lammert F; Zaldivar MM; Weiskirchen R; Hellerbrand C; Scholten D; Berres ML; Zimmermann H; Streetz KL; Tacke F; Hillebrandt S; Schmitz P; Keppeler H; Berg T; Dahl E; Gassler N; Friedman SL; Trautwein C
    Gastroenterology; 2009 Jul; 137(1):309-19, 319.e1-3. PubMed ID: 19344719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced expression of CXCL10 in inflammatory bowel disease: potential role of mucosal Toll-like receptor 3 stimulation.
    Ostvik AE; Granlund AV; Bugge M; Nilsen NJ; Torp SH; Waldum HL; Damås JK; Espevik T; Sandvik AK
    Inflamm Bowel Dis; 2013 Feb; 19(2):265-74. PubMed ID: 22685032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of monokine induced by interferon-gamma/chemokine (C-X-X motif) ligand 9, thymus and activation-regulated chemokine/chemokine (C-C motif) ligand 17 in children with Kawasaki disease.
    Feng S; Yadav SK; Gao F; Yi Q
    BMC Pediatr; 2015 Sep; 15():109. PubMed ID: 26337791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypersensitivity pneumonitis and alpha-chemokines.
    Limongi F; Fallahi P
    Clin Ter; 2017; 168(2):e140-e145. PubMed ID: 28383627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.